NSE filing, NSE: ONYX. Summary written from the filing by ALFA Finder's alert engine.
Onyx Biotec Ltd: key numbers
- Share price
- ₹36.00
- Market cap
- ₹65.28 Cr
- Revenue (annual)
- ₹69.47 Cr
- Net profit (annual)
- ₹-0.21 Cr
- P/E (TTM)
- -304.5×Sector 46.1×
- Promoter holding
- 41.74%
- FII holding
- 0.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Onyx Biotec Ltd
All →Onyx Biotec Other Announcement
Onyx Biotec Limited has submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Onyx Biotec Open Offer
Onyx Biotec's Committee of Independent Directors met to review the open offer by the identified acquirers to purchase 26% of the company's equity share capital.
Onyx Biotec Open Offer: ₹17.21 Cr
Bhardwaj acquirers launch a ₹172.07 Crore open offer for 26% of Onyx Biotec at ₹36.5 per share. Tendering runs October 13–27, 2026.
- Value
- ₹17.21 Cr
Onyx Biotec Annual General Meeting
Onyx Biotec Limited held its 21st Annual General Meeting on September 28, 2026. The meeting covered standard agenda items including financial statement adoption and director appointments.
Onyx Biotec Annual General Meeting
Onyx Biotec Limited will hold its 21st Annual General Meeting on September 28, 2026, via video conferencing to transact the company's business.
Onyx Biotec Management Change
Onyx Biotec Limited has announced a change in the designation of Mr. Naresh Kumar from Whole-Time Director to Executive Director, effective September 3, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.